Delivery Order SPE2DB25D3012-SPE2DB25FWWUC
Award Date
4/10/25
Potential Completion Date
4/11/25
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB22D1106|SPE2DB25FEJP1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,579.86 firm fixed-price delivery order is for the supply of 4,567,968,732 units of the prescription medication Vyvanse 40 mg capsules. The contract has an ultimate completion date of April 21, 2025 and was awarded on April 18, 2025. This award is not a set-aside contract....
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,971.32 firm fixed-price delivery order is for the supply of 100 units of the medication Vyvanse 40 mg capsules. The contract has an ultimate completion date of June 11, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, with ID SPE2DB25D3306|SPE2DB25FUBRA, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,850.96 delivery order contract is for the supply of 4,568,203,068 units of the drug Vyvanse 60 mg capsules. The contract is a firm fixed-price, non-set-aside award with a completion date of May 12, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,103.02 firm fixed-price delivery order is for the supply of 4,568,072,848 units of the prescription medication Vyvanse 40 mg capsules. The contract has an ultimate completion date of April 29, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This federal contract award, with ID SPE2DB22D3301|SPE2DB25FY3QY, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,536.64 firm fixed-price delivery order is for the supply of 4,568,000 units of the 40mg capsule formulation of the medication Vyvanse. The contract has an ultimate completion date of April 23, 2025 and does not utilize any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award, SPE2DB22D3004|SPE2DB25FQG61, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,485.49 firm fixed-price delivery order is for the supply of 4,567,955,619 units of the prescription medication Vyvanse 40 mg capsules. The contract has an ultimate completion date of April 16, 2025 and does not utilize any set-aside designations, indicating open competition....
This federal contract award, with ID SPE2DB20D1004|SPE2DB24FF2V4, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,069.14 firm fixed-price delivery order is for the supply of 4563430867 Vyvanse 40 mg capsules. The contract has an ultimate completion date of January 25, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider, registered in the System for Award Management (SAM.gov) since...
This federal contract award, with ID SPE2DB24D2205|SPE2DB25FEBRF, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,518.70 firm fixed-price delivery order is for 4,568,076,830 units of the prescription medication Vyvanse 30 mg capsules. The contract has an ultimate completion date of April 30, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,978.62 firm fixed-price delivery order is for the supply of 100-count capsules of the medication Vyvanse (40 mg). The contract has a performance period ending on May 6, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $1,377.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,172,639 units of Vyvanse 60 mg capsules. The contract has a firm fixed price pricing type and an ultimate completion date of May 8, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...